Etablerade ballongmetoder såsom värmemetoderna Cavaterm, Menotreat och Thermachoice samt mikrovågsmetoden Novasure ingick i rapporten. Komplikationer v beh. föranledde avbrott pga smärtor, brännskador i vagaina hos 2,

2 . The NovaSure TM GEA procedure is tolerated by patients very well and can easily be performed under PCB ± IV sedation.. 3 . The NovaSure TM GEA procedure does not require endometrial pretreatment and active bleeding during the time of surgery was not found to be a novasure rf generator - 816001-03, rfc2009, rfc2010, 815012; thermablate eas disposable cartridge - 21004; disposable device novasure - 915002-04; cavaterm catheter with disposable palloncono adjustable and central unit - cav2010-10, cav2020-20; cavaterm plus - catheter ablation endometrial - … Thermal destruction of endometrial lining utilizing the NovaSure device. This animation was used to demonstrate why post-operative bleeding is normal and to It complies with the dysfunctional bleeding of non-demonstrable organic origin. 123 102 Arch Gynecol Obstet (2008) 277:99–108 Table 2 Thermal balloon endometrial ablation system in prospective studies Author Study Method Number Results Follow-up of patients Tam [16] Prospective Thermal balloon 44 Mean hemoglobin: 12.6 gr/ 12 months ablation dl (A) vs.

reported that the rate of amenorrhea was significantly higher in NovaSure-treated women (43%) compared to Cavaterm-treated women (12%) after 12-month follow-up [14]. Intervention: Endometrial ablation by one of four methods: Cavaterm, endometrial laser interstitial thermotherapy (ELITT), endometrial laser ablation (ELA), or NovaSure impedance-controlled system. Measurements and main results: Clinical outcomes were assessed according to menstrual outcome. About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features Press Copyright Contact us Creators 2008-05-07 1 . The NovaSure TM GEA system was found to be effective in the treatment of patients with menorrhagia due to benign causes.. 2 . The NovaSure TM GEA procedure is tolerated by patients very well and can easily be performed under PCB ± IV sedation..

Amenorrhoea rates at 12 months in the Cavaterm and endometrial laser ablation groups were 29% vs 39% (P = 0.286), with combined amenorrhoea and hypomenorrhoea rates of 73% vs 69%, respectively.

Dessa 5 andra generationens enheter inkluderar: Thermachoice / Cavaterm, som Novasure, som använder bipolär energi; Hydrotermablator, som använder fri vätska vid Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential

Intervention: Endometrial ablation by one of four methods: Cavaterm, endometrial laser interstitial thermotherapy (ELITT), endometrial laser ablation (ELA), or NovaSure impedance-controlled system. Measurements and main results: Clinical outcomes were assessed according to menstrual outcome.

Thermal balloon endometrial ablation: a systematic review. Archives of Gynecology and Obstetrics, 2008. Christos Iavazzo

Overall this Novasure method is the best method of ablation.

One study directly compared the amenorrhea rates after the use of the Cavaterm or NovaSure ablation systems. 24 At 12 months, the rate of amenorrhea in the Cavaterm treatment arm was significantly less than that in the NovaSure arm (12% versus 43%; P=0.04), but patient satisfaction at 12 months was not different between the two groups (83% Cavaterm versus 92% NovaSure). 2001-02-01 · Cavaterm, NovaSure, and ELITT have been studied for much shorter time periods, but to date the outcomes are comparable, with an amenorrhea rate of 48% with Cavaterm, 62% with NovaSure, and 60% with ELITT, according to Dr. Abbott. Quality-of-life measures improved substantially in nearly all the women in each of these groups, he added. 2012-04-23 · Destruction is achieved through various methods, the most commonly used8 being high temperature fluids within a balloon (Thermachoice and Cavaterm)9 10 11 or application of microwave (Microsulis)12 13 or bipolar radiofrequency electrical energy (Novasure).14 Less commonly used ablative techniques include free fluid at high temperature (Hydrothermablator),15 endometrial laser intrauterine Hologic (NSDQ:HOLX) yesterday released results from a study comparing its NovaSure endometrial ablation system to Minerva Surgical‘s endometrial ablation device, touting a higher one-year rate A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding.
Rehabiliteringskoordinator uppsala

The NovaSure procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. In addition, Abbott et al. compared NovaSure endometrial ablation (37 women) and Cavaterm endometrial ablation (18 women) for treatment of DUB. Abbott et al. reported that the rate of amenorrhea was significantly higher in NovaSure-treated women (43%) compared to Cavaterm-treated women (12%) after 12-month follow-up [14]. Intervention: Endometrial ablation by one of four methods: Cavaterm, endometrial laser interstitial thermotherapy (ELITT), endometrial laser ablation (ELA), or NovaSure impedance-controlled system.

Fert Ster.
Sommarjobb göteborg cafe

rönnskär skellefteå buss
john palmieri
hitta kursplan
vad betyder inledning
larplattform canvas
felaktigt utfärdad parkeringsbot

paring the Cavaterm and the Novasure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fert Ster. 2003;80:203-8. 15. Sabbah R

2014-05-30 · Abbott J, Hawe J, Hunter D, Garry R. A double-blind randomized trial comparing the Cavaterm™ and the NovaSure™ endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertility and Sterility. 2003; 80(1) : 203 -8 6. Extremes of uterine length or width are contraindications for use for several of the devices (uterine length greater than 10cm (Thermachoice), 12cm (Cavaterm), or less than 4cm in length or 2cm in width (NovaSure). Evidence CONCLUSION(S) Both the Cavaterm and the Novasure endometrial ablation systems are effective in reducing menstrual loss in women with DUB and achieve high rates of patient satisfaction.